enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. EpiPen Alternative for Anaphylaxis Approved by FDA - AOL

   www.aol.com/epipen-alternative-anaphylaxis...

   The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has been approved by the Food and Drug Administration to treat anaphylaxis.. Neffy, a nasal spray that ...

3. What is Neffy? FDA approves first nasal spray to treat severe ...

   www.aol.com/neffy-fda-approves-first-nasal...

   The US Food and Drug Administration has approved the first nasal medicine to treat severe allergies.On 9 August, US health officials approved the first nasal spray to treat allergic reactions from ...

4. FDA-approved nasal spray for severe depression can lead to ...

   www.aol.com/fda-approved-nasal-spray-severe...

   The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

5. Insignis Therapeutics Announces Positive Results from Phase 1 ...

   lite.aol.com/tech/story/0022/20241007/9251898.htm

   Importantly, 100% of subjects treated with the 9.06 mg dose reached or exceeded this threshold within the clinically relevant first 30 minutes after dosing, outperforming existing epinephrine products including the recently approved epinephrine nasal spray Neffy, where 2% to 17% of subjects failed to reach 100 pg/mL within the same timeframe ...

6. Epinephrine (medication) - Wikipedia

   en.wikipedia.org/wiki/Epinephrine_(medication)

   Epinephrine is available in an autoinjector delivery system and a nasal spray. There is an epinephrine metered-dose inhaler sold over the counter in the United States to relieve bronchial asthma. [67] [68] It was introduced in 1963 by Armstrong Pharmaceuticals. [69]

7. ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 ...

   lite.aol.com/tech/story/0022/20250113/9330688.htm

   SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced preliminary, unaudited neffy ® (epinephrine nasal spray) net product ...